Last deal

$2.82M
Local Amount - EUR 2.5M

Amount

Grant

Stage

20.12.2021

Date

3

all rounds

$58.72M

Total amount

date founded

Financing round

General

About Company
VBL Therapeutics is a clinical stage biotech company that develops innovative treatments for cancer and immune-inflammatory diseases.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2000

founders

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

The company uses proprietary platform technologies to create new treatment options that address unmet medical needs. VBL has two programs based on these platforms - an oncology program and an anti-inflammatory program. Its lead immunology product candidate, VB-601, is a targeted antibody for immune-inflammatory applications that has shown disease-modifying activity across multiple preclinical models including multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease. VB-601 is expected to enter Phase 1 this year. VBL Therapeutics is listed on Nasdaq under the ticker symbol VBLT.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Aduro BioTech

Aduro BioTech

Aduro BioTech develops and sells therapies that use the body's immune system to treat diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Biopharma

Location

Berkeley, CA, USA

total rounds

12

total raised

$359.66M
Vera Therapeutics

Vera Therapeutics

Vera Therapeutics develops transformative treatments for immunological diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

South San Francisco, CA, USA

total rounds

7

total raised

$596.4M
MBX Biosciences

MBX Biosciences

MBX Biosciences creates therapies to treat rare endocrine diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Carmel, IN, USA

total rounds

4

total raised

$238.4M
Allakos

Allakos

Allakos develops antibody-based therapeutics to treat diseases associated with dysregulation of the T-helper type 2 immune response.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

San Carlos, CA, USA

total rounds

5

total raised

$312.45M
M&A Details
1

Transaction name

Acquired by

Notable Labs

announced date

16.10.2023

Financials

Funding Rounds
6
3

Number of Funding Rounds

$58.72M

Money Raised

Their latest funding was raised on 20.12.2021. Their latest investor European Innovation Council. Their latest round Grant

Date 
Funding Round 
Investors 
Money Raised 
Lead 
20.12.2021
1
$2.82M
Local Amount - EUR 2.5M
20.12.2021
1
$16.92M
Local Amount - EUR 15M
01.04.2021
1
$28.41M
European Innovation Council

European Innovation Council

The EIC pilot supports innovators and entrepreneurs by providing funding, advice, and networking opportunities for cutting-edge innovation.

Sector

Media

Subsector

Media Agencies

Keywords

Consulting

Location

Brussels, Belgium

count Of Investments

1179

count Of Exists

5
European Innovation Council

European Innovation Council

The EIC pilot supports innovators and entrepreneurs by providing funding, advice, and networking opportunities for cutting-edge innovation.

Sector

Media

Subsector

Media Agencies

Keywords

Consulting

Location

Brussels, Belgium

count Of Investments

1179

count Of Exists

5
Co-Investors
Investors
4
2

Number of lead investors

4

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Grant, Post-IPO Equity
No
Post-IPO Equity
European Innovation Council

European Innovation Council

The EIC pilot supports innovators and entrepreneurs by providing funding, advice, and networking opportunities for cutting-edge innovation.

Sector

Media

Subsector

Media Agencies

Keywords

Consulting

Location

Brussels, Belgium

count Of Investments

1179

count Of Exists

5
Israel Innovation Authority

Israel Innovation Authority

The Israel Innovation Authority manages the country's governmental support of innovation.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Government, Association

Location

Jerusalem, Israel

count Of Investments

153

count Of Exists

7
ROTH Capital Partners

ROTH Capital Partners

ROTH Capital Partners is an investment banking firm focused on the small-cap public market.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Location

Newport Beach, CA, USA

count Of Investments

34

count Of Exists

6

People

Founders
1
Dror Harats
Dror Harats

Dror Harats

Prof. Harats founded VBL in 2000 based on more than 15 years of research in atherosclerosis, vascular biology and lipid metabolism. He is the Director of the Bert W. Strassburger Lipid Center at Chaim Sheba Medical Center – Tel Hashomer and Chairman of its Institute Review Board and has consulted with major pharmaceutical companies. Prof Harats is an M.D. graduate of the Hadassah Medical School, Jerusalem, Israel, and has carried out post-doctoral work at University of California, San Francisco. He is also a Professor of Medicine in the Departments of Internal Medicine and Biochemistry at the Sackler Faculty of Medicine of Tel Aviv University.

current job

VBL THERAPEUTICS
VBL THERAPEUTICS

organization founded

1

Dror Harats

Employee Profiles
6
Sam Backenroth

Sam Backenroth

Chief Financial Officer

Dror Harats

Dror Harats

CEO

Yael Cohen

Yael Cohen

VP Clinical Development

Amos Ron

Amos Ron

Chief Financial Officer

Jide Zeitlin

COO

Activity

Recent News
0